Abstract
ErbB-2 is a critical oncogenic marker in human breast cancer. Its appearance correlates with poor prognosis and it is, therefore, an important target for physiologic investigation and therapeutic intervention. With this in mind, we have created and characterized two mouse breast cancer models that express rat wild type neu, the homologue of ErbB-2, and rat mutant neu under the control of the normal mouse neu promoter. These models in which the copy number of the neu gene is moderately amplified should more closely parallel the expression pattern of ErbB-2 seen in some cases of human breast cancer. Transgenic mouse models were constructed by injecting one of the two pronuclei of a fertilized FVB/n egg and implanting it into a pseudopregnant Swiss /Webster mouse. Tissue expression was analyzed through the use of reverse transcription polymerase chain reaction and mammary histopathology examined by fixing, staining and mounting of the entire gland. In the former wild type model, we show that low level, long term expression of neu leads to abnormal lobuloalveolar development in virginal glands and incomplete regression in multiparous glands. Malignant foci form following multiple rounds of pregnancy and regression. In the latter model, a similarly directed transgene carrying the constitutively activated, mutant form of the rat neu gene, a stronger but similar phenotype is displayed. Evidently minor perturbations in amplified neu expression are sufficient to alter mammary development and induce malignant transformation.
Highlights
The neu oncogene was first isolated from DNA of adrenal neuroblastomas of neonatal rats [1]
The RT-polymerase chain reaction (PCR) was performed on a cell line, termed 980NF, established from a mammary gland tumor excised from an mammary tumor virus (MMTV)/neu* transgenic mouse [18], which served as a positive control
Multiple clones of cells transfected with the neu promoter/neu transgene construct do transcribe the transgene from the murine promoter (Fig. 1A), showing that the promoter is active in mammary cells
Summary
The neu oncogene was first isolated from DNA of adrenal neuroblastomas of neonatal rats [1]. Its appearance correlates with poor prognosis and it is, an important target for physiologic investigation and therapeutic intervention With this in mind, we have created and characterized two mouse breast cancer models that express rat wild type neu, the homologue of ErbB-2, and rat mutant neu under the control of the normal mouse neu promoter. We have created and characterized two mouse breast cancer models that express rat wild type neu, the homologue of ErbB-2, and rat mutant neu under the control of the normal mouse neu promoter These models in which the copy number of the neu gene is moderately amplified should more closely parallel the expression pattern of ErbB-2 seen in some cases of human breast cancer. Conclusion: minor perturbations in amplified neu expression are sufficient to alter mammary development and induce malignant transformation
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
